Home Conference Coverage

Conference Coverage

Clinical Trial Finds More Targetable Genetic Alterations in Pediatric Cancers

At the launch of the National Cancer Institute-Children’s Oncology Group Pediatric Molecular Analysis for Therapy Choice (NCI-COG Pediatric MATCH) trial in 2017,...

Entrectinib Benefits Children and Adolescents with CNS and Other Cancers That...

In a phase I/IB study of 29 patients, age 4.9 months to 20 years, with rare central nervous system (CNS) tumors,...

Lenalidomide Significantly Reduces the Risk of Smoldering Multiple Myeloma from Progressing

The phase II/III E3A06 randomized clinical trial (NCT01169337), funded by the National Institutes of Health (NIH), found that lenalidomide (Revlimid®; Celgene), significantly...

Sanofi’s Oncology Targets Highlighted at Annual ASCO Meeting

During the upcoming annual meeting American Society of Clinical Oncology (ASCO) in June 2019, Sanofi's oncology franchise will present a renewed strategy...

Optimizing Chemotherapy: Low-Dose Regimen Effective in Older and Frail Gastroesophageal Cancer...

The phase III GO2 randomized trial of 514 older and frail people in the United Kingdom with advanced gastroesophageal cancer found...

High Risk for HIV Infection Linked to Low Rates of Vaccination...

Results from a study, funded by a career development award from the National Cancer Institute (NCI) and presented at the AACR Annual...

CD166 Expression Level and Anti-Cancer Activity Confirm Potential for Combination of...

Clinical and preclinical data for CX-2009, a Probody-drug Conjugate or PDC designed to target the cell surface protein CD166 and deliver the...

Anti-CD99 Targeted Nanosphere Shows Potential in Ewing’s Sarcoma

Despite key-advances in the development of novel anti-cancer therapeutics, off-target, adverse, effects plague drug developers. One reason is that standard chemotherapeutic...

Misdiagnosis of Colorectal Cancer May Be Common in People Younger than...

Results of a survey funded by the Colorectal Cancer Alliance and presented during a preview meeting of the Annual Meeting of the America Association...

Despite Receiving Similar Treatment as White Women, Black Women have Worse...

Breast cancer is the most common cancer in women in the United States and worldwide. Furthermore, hormone-receptor–positive, axillary node–negative disease accounts for approximately half...